These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sporadic Creutzfeldt-Jakob disease infected human cerebral organoids retain the original human brain subtype features following transmission to humanized transgenic mice. Groveman BR; Race B; Foliaki ST; Williams K; Hughson AG; Baune C; Zanusso G; Haigh CL Acta Neuropathol Commun; 2023 Feb; 11(1):28. PubMed ID: 36788566 [TBL] [Abstract][Full Text] [Related]
3. Human cerebral organoids as a therapeutic drug screening model for Creutzfeldt-Jakob disease. Groveman BR; Ferreira NC; Foliaki ST; Walters RO; Winkler CW; Race B; Hughson AG; Zanusso G; Haigh CL Sci Rep; 2021 Mar; 11(1):5165. PubMed ID: 33727594 [TBL] [Abstract][Full Text] [Related]
4. Neural cell engraftment therapy for sporadic Creutzfeldt-Jakob disease restores neuroelectrophysiological parameters in a cerebral organoid model. Williams K; Foliaki ST; Race B; Smith A; Thomas T; Groveman BR; Haigh CL Stem Cell Res Ther; 2023 Dec; 14(1):348. PubMed ID: 38049877 [TBL] [Abstract][Full Text] [Related]
5. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part II]. Zaborowski A Psychiatr Pol; 2004; 38(2):297-309. PubMed ID: 15307294 [TBL] [Abstract][Full Text] [Related]
6. Stress and viral insults do not trigger E200K PrP conversion in human cerebral organoids. Smith A; Groveman BR; Winkler C; Williams K; Walters R; Yuan J; Zou W; Peterson K; Foliaki ST; Haigh CL PLoS One; 2022; 17(10):e0277051. PubMed ID: 36301953 [TBL] [Abstract][Full Text] [Related]
7. Postmortem Quantitative Analysis of Prion Seeding Activity in the Digestive System. Satoh K; Fuse T; Nonaka T; Dong T; Takao M; Nakagaki T; Ishibashi D; Taguchi Y; Mihara B; Iwasaki Y; Yoshida M; Nishida N Molecules; 2019 Dec; 24(24):. PubMed ID: 31888217 [TBL] [Abstract][Full Text] [Related]
8. Prion-Seeding Activity Is widely Distributed in Tissues of Sporadic Creutzfeldt-Jakob Disease Patients. Takatsuki H; Fuse T; Nakagaki T; Mori T; Mihara B; Takao M; Iwasaki Y; Yoshida M; Murayama S; Atarashi R; Nishida N; Satoh K EBioMedicine; 2016 Oct; 12():150-155. PubMed ID: 27612591 [TBL] [Abstract][Full Text] [Related]
10. Emergence of two prion subtypes in ovine PrP transgenic mice infected with human MM2-cortical Creutzfeldt-Jakob disease prions. Chapuis J; Moudjou M; Reine F; Herzog L; Jaumain E; Chapuis C; Quadrio I; Boulliat J; Perret-Liaudet A; Dron M; Laude H; Rezaei H; Béringue V Acta Neuropathol Commun; 2016 Feb; 4():10. PubMed ID: 26847207 [TBL] [Abstract][Full Text] [Related]
11. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease. Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604 [TBL] [Abstract][Full Text] [Related]
12. Cerebral amyloid angiopathy with co-localization of prion protein and beta-amyloid in an 85-year-old patient with sporadic Creutzfeldt-Jakob disease. Paquet C; Privat N; Kaci R; Polivka M; Dupont O; Haïk S; Laplanche JL; Hauw JJ; Gray F Acta Neuropathol; 2008 Nov; 116(5):567-73. PubMed ID: 18551298 [TBL] [Abstract][Full Text] [Related]
13. The Braak hypothesis in prion disease with a focus on Creutzfeldt-Jakob disease. Iwasaki Y Neuropathology; 2020 Oct; 40(5):436-449. PubMed ID: 32363728 [TBL] [Abstract][Full Text] [Related]
14. [Creutzfeldt-Jakob disease--a human prion disease]. Buchwald E; Vorstrup S Nord Med; 1996 Jun; 111(6):180-3. PubMed ID: 8700643 [TBL] [Abstract][Full Text] [Related]
15. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Budka H; Aguzzi A; Brown P; Brucher JM; Bugiani O; Gullotta F; Haltia M; Hauw JJ; Ironside JW; Jellinger K Brain Pathol; 1995 Oct; 5(4):459-66. PubMed ID: 8974629 [TBL] [Abstract][Full Text] [Related]
16. Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease. Ironside JW; Head MW Curr Top Microbiol Immunol; 2004; 284():133-59. PubMed ID: 15148991 [TBL] [Abstract][Full Text] [Related]
17. Pathologic prion protein spreading in the peripheral nervous system of a patient with sporadic Creutzfeldt-Jakob disease. Favereaux A; Quadrio I; Vital C; Perret-Liaudet A; Anne O; Laplanche JL; Petry KG; Vital A Arch Neurol; 2004 May; 61(5):747-50. PubMed ID: 15148153 [TBL] [Abstract][Full Text] [Related]
18. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease. Llorens F; Zafar S; Ansoleaga B; Shafiq M; Blanco R; Carmona M; Grau-Rivera O; Nos C; Gelpí E; Del Río JA; Zerr I; Ferrer I Neuropathol Appl Neurobiol; 2015 Aug; 41(5):631-45. PubMed ID: 25134744 [TBL] [Abstract][Full Text] [Related]
20. Inactivation of the causal agents of Creutzfeldt-Jakob disease and other human prion diseases. Taylor D Brain Pathol; 1996 Apr; 6(2):197-8. PubMed ID: 8737933 [No Abstract] [Full Text] [Related] [Next] [New Search]